Hyderabad: Phase I clinical trials of ` Covaxin' has shown that the vaccine is safe and generates a desired immune response.Developed by India's leading drugmaker `Bharat Biotech', the result of the vaccine was published on medrxiv.org.It said that the vaccine did not show any major adverse reaction...